SenesTech Inc. (NASDAQ: SNES) Anticipates Growth in Product Demand Amid Rising Cases of Human Leptospirosis
SenesTech, a rodent fertility control product provider, is projecting an increase in demand for its Evolve(TM) Soft Bait This follows the rising cases of human leptospirosis in New York, an infection associated with exposure to rat urine Evolve offers a humane approach to controlling the rodent population, with the potential for complete elimination in 12 to 18 months Evolve contributes a significant chunk of SenesTech’s revenue, and the company projects that this will continue to be the case given recent developments SenesTech (NASDAQ: SNES), a rodent fertility control product provider, and inventor of the only EPA-registered contraceptive for male and…